300 related articles for article (PubMed ID: 19663845)
1. Opioid-induced pruritus: an update.
Reich A; Szepietowski JC
Clin Exp Dermatol; 2010 Jan; 35(1):2-6. PubMed ID: 19663845
[TBL] [Abstract][Full Text] [Related]
2. [Opioid-induced pruritus].
Frost J; Spigset O
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2180-1. PubMed ID: 23076488
[TBL] [Abstract][Full Text] [Related]
3. Intravenous nalbuphine 50 microg x kg(-1) is ineffective for opioid-induced pruritus in pediatrics.
Nakatsuka N; Minogue SC; Lim J; Montgomery CJ; Court CA; Malherbe S; Csanyi-Fritz Y; Kearney RA; Phillips L; Reid K; Kingsley J; Ansermino JM
Can J Anaesth; 2006 Nov; 53(11):1103-10. PubMed ID: 17079637
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
Tamdee D; Charuluxananan S; Punjasawadwong Y; Tawichasri C; Patumanond J; Sriprajittichai P
Anesth Analg; 2009 Nov; 109(5):1606-11. PubMed ID: 19843798
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
7. Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies.
Reich A; Szepietowski JC
Curr Pharm Des; 2012; 18(37):6021-4. PubMed ID: 22747545
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and treatment of opioid-induced pruritus: Peripheral and central pathways.
Okutani H; Lo Vecchio S; Arendt-Nielsen L
Eur J Pain; 2024 Feb; 28(2):214-230. PubMed ID: 37650457
[TBL] [Abstract][Full Text] [Related]
9. Treatment of opioid-induced pruritus with ondansetron: report of four patients.
Larijani GE; Goldberg ME; Rogers KH
Pharmacotherapy; 1996; 16(5):958-60. PubMed ID: 8888093
[TBL] [Abstract][Full Text] [Related]
10. The effect of celecoxib on intrathecal morphine-induced pruritus in patients undergoing Caesarean section.
Lee LH; Irwin MG; Lim J; Wong CK
Anaesthesia; 2004 Sep; 59(9):876-80. PubMed ID: 15310350
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous naloxone for the prevention of intrathecal morphine induced pruritus in elective Caesarean delivery.
Lockington PF; Fa'aea P
Anaesthesia; 2007 Jul; 62(7):672-6. PubMed ID: 17567342
[TBL] [Abstract][Full Text] [Related]
12. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
Ajayi AA; Kolawole BA; Udoh SJ
Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
[TBL] [Abstract][Full Text] [Related]
13. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Tandon P; Rowe BH; Vandermeer B; Bain VG
Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
[TBL] [Abstract][Full Text] [Related]
15. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines.
Dunteman E; Karanikolas M; Filos KS
J Pain Symptom Manage; 1996 Oct; 12(4):255-60. PubMed ID: 8898510
[TBL] [Abstract][Full Text] [Related]
16. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice.
Yamamoto A; Kuyama S; Kamei C; Sugimoto Y
Eur J Pharmacol; 2010 Feb; 627(1-3):162-6. PubMed ID: 19900440
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
18. Opioid-induced bowel dysfunction.
Thomas J
J Pain Symptom Manage; 2008 Jan; 35(1):103-13. PubMed ID: 17981003
[TBL] [Abstract][Full Text] [Related]
19. Nalbuphine and pruritus.
Elias M
Anaesthesia; 1997 Jun; 52(6):613. PubMed ID: 9203908
[No Abstract] [Full Text] [Related]
20. Neuraxial opioid-induced pruritus: a review.
Szarvas S; Harmon D; Murphy D
J Clin Anesth; 2003 May; 15(3):234-9. PubMed ID: 12770663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
